Rejuvenation Technologies

Mountain View, United States

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.

Oct 2023

Venture - Series Unknown

Biotechnology Health Care

Top Investors

Y CombinatorKhosla VenturesLongevitytech.fund99 StartupsAsymmetry Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rejuvenation Technologies

Who are Rejuvenation Technologies's investors?

Rejuvenation Technologies's investors include Y Combinator, Khosla Ventures, Longevitytech.fund, 99 Startups, Asymmetry Ventures.

Where is Rejuvenation Technologies headquartered?

Rejuvenation Technologies is headquartered in Mountain View, United States.

What does Rejuvenation Technologies do?

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.

What stage is Rejuvenation Technologies at?

Rejuvenation Technologies is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 11, 2023.

MLA

"Rejuvenation Technologies — Funding & Investors." VCBacked, October 11, 2023, https://www.vcbacked.co/company/rejuvenation-technologies. Accessed June 9, 2026.

APA

VCBacked. (2023). Rejuvenation Technologies — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/rejuvenation-technologies

Wikipedia (cite web)

{{cite web |title=Rejuvenation Technologies — Funding & Investors |url=https://www.vcbacked.co/company/rejuvenation-technologies |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 11, 2023.